WithdrawnNCT01015066
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
Medication studyAges 16–25United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 16 years to 25 years.
- Listed locations
- BuffaloSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2009
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- State University of New York at Buffalo
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 16 Years to 25 Years
- Official registry ID
- NCT01015066
- Official title
Show the full official title
A Randomized Controlled Trial Comparing Buprenorphine/Naloxone With Naltrexone for Treatment in Opioid Dependent Adolescents and Young Adults
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Buffalo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is State University of New York at Buffalo, a university.
Does this study involve medication?
Yes. The study involves medication, including Buprenorphine/naloxone and Naltrexone.
Who can participate?
Listed age limits: 16 years to 25 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
